Here's mine (substantially based on some of the excellent recent...

Here's mine (substantially based on some of the excellent recent research from SUD posters on HC) but with no concrete insights, because who knows what happens in the SUD boardroom ...

The tone of my negotiation is -

"mate, I'm just here to get some more frequent flyer points, I'm about to get upgraded to a black card".

So with that as a starting point -

- I'd be having Lovell's to work outlining why the administrators wouldn't win a court case, based on a preponderance of evidence (or whatever the kraut equivalent is) that is at hand.

- Next, I would be having Lovell's provide an estimate of how much the administrators are in the red (financially) having been involved with this farce for the last 5 (ish) years.

- Following that is that we really aren't interested in mediation and that we are quite happy about contesting the claim. Firstly, because we aren't gunna sell artimist in the near future because no one's interested and secondly because our product pipeline is such that we don't really need artimist and because we've found the holy grail of oro-mucosal drug delivery (editors note: supposedly).

Carter says -

"But sht guy's I'm prepared to negotiate because there are a bunch of wakers on social media that are giving me grief. I reckon that the manufacturing and 'alleged' distribution rights are worth sfa. So I'm prepared to offer you clowns Euros 150K to partly compensate for your expenses - take it or leave it"

Now Carter has shown some expertise in negotiations despite some HC posters assertions:

- The job he did with the vulture fund Bergen was strategic in the long term survival of the Company, no question about that.
- When he negotiated the acquisition for final 20% of the rights (albeit restricted) for a million or so pounds, EUR or AUS or whatever, when the mining boom went bust and Timis corp was doing a fire sale, was also strategic.
- The latest deal with Zolpi was not a bad deal. Dad and Dave were suffering and the re-negotiation to obtain a bunch of territories outside those of the original agreement (at 50% share deal) was not a bad one either.

So time will tell and I wouldn't be surprised to see an extension of the existing voluntary suspension.

If artimist were to be trade-saled then this encumbrance needs to be resolved but not at the significant expense of shareholders.

If a deal is to be struck then it needs to be contingent on the date of a significant deal (from the pipeline) that offer's immediate income (paid into a SUD bank account) at least 10x what the mediation agreement is.

By the way check this out. Drug resistant malaria has been found in the UK. It's an artemisinin combination therapy ( artemether-lumefantrine). Look out.